North America Graft-Versus-Host Disease GVHD Treatment Market

Published Apr 01, 2024

Length 224 Pages

SKU # DAABD18813140

Description

North America Graft-Versus-Host Disease GVHD Treatment Market

North America Graft-Versus-Host Disease (GVHD) treatment market is expected to reach USD 2,368,824.57 thousand by 2031, from USD 1,560,634.00 thousand in 2023 growing at the CAGR of 5.5% in the forecast period of 2024 to 2031.
Market Segmentation:
Global Graft-Versus-Host Disease (GVHD) Treatment Market, By Treatment (Medication and Therapy), Type (Chronic GVHD, Acute GVHD, and Prophylactic), Gender (Female and Male), Age (Adults and Pediatric), Method of Administration (Oral, Intravenous, Topical, and Others), End User (Hospitals, Transplant Centers, Institutes and Specialty Centers), Distribution Channel (Direct Tender, Retail Sales and Others), By Country (U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Belgium, Russia, Switzerland, Denmark, Rest of Europe, China, Japan, Australia, South Korea, India, Malaysia, Singapore, Philippines, Indonesia, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Kuwait, Bahrain, and Rest of Middle East and Africa)– Industry Trends and Forecast to 2031
Overview of North America Graft-Versus-Host Disease (GVHD) Treatment Market Dynamics:

Drivers
• Increasing incidence of hematopoietic stem cell transplants (HSCT)
• Awareness campaigns and patient education
• Advancements in treatment options

Restraints
• High cost of medications and supportive care
• Disease heterogeneity

Opportunities
• Market expansion through strategic initiatives and partnership
• Growing pipeline of innovative drugs for GVHD treatment
• Empowering patient centric approach to GVHD treatment
Challenges
• Stringent regulations in GVHD therapies
• Safety concerns and complexities during treatment

Market Players

The key market players for North America Graft-Versus-Host Disease (GVHD) treatment market are listed below:
• Bristol-Myers Squibb Company
• AbbVie Inc
• Novartis AG
• Janssen Global Services, LLC
• Mallinckrodt
• Incyte
• Sanofi
• Alkem Laboratories Ltd
• Astellas Pharma Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Graft-versus-host Disease (Gvhd) Treatment Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 DBMR Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Market Application Coverage Grid; 2.8 DBMR Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Secondary Sources; 2.11 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis_; 4.2 Porter's Five Forces Model
5 Pipe Line Analysis Of Graft Versus Host Disease Market
6 Regulation
7 Market Overview: 7.1 Drivers; 7.1.1 Increasing Incidence Of Hematopoietic Stem Cell Transplants (Hsct); 7.1.2 Awareness Campaigns And Patient Education; 7.1.3 Advancements In Treatment Options; 7.2 Restraints; 7.2.1 High Cost Of Medications And Supportive Care; 7.2.2 Disease Heterogeneity; 7.3 Opportunities; 7.3.1 Market Expansion Through Strategic Initiatives And Partnership; 7.3.2 Growing Pipeline Of Innovative Drugs For Gvhd Treatment; 7.3.3 Empowering Patient-centric Approach To Gvhd Treatment; 7.4 Challenges; 7.4.1 Stringent Regulations In Gvhd Therapies; 7.4.2 Safety Concern And Complexities During Treatment
8 North America Graft-versus-host-disease (Gvhd) Treatment Market, By Type: 8.1 Overview; 8.2 Chronic Gvhd; 8.2.1 Corticosteroids; 8.2.1.1 Prednisolone; 8.2.1.2 Methylprednisolone; 8.2.2 Immunosuppressive; 8.2.2.1 Mycophenolate Mofetil (Mmf); 8.2.2.2 Methotrexate (Mtx); 8.2.2.3 Ibrutinib; 8.2.2.4 Belumosudil; 8.2.2.5 Ruxolitinib; 8.2.2.6 Antithymocyte Globulin (Atg); 8.2.2.7 Others; 8.2.3 Calcineurin Inhibitors; 8.2.4 Others; 8.2.4.1 Branded; 8.2.4.1.1 Rezurock; 8.2.4.1.2 Imbruvica; 8.2.4.1.3 Jakafi; 8.2.4.2 Generic; 8.3 Acute Gvhd; 8.3.1 Corticosteroids; 8.3.1.1 Methylprednisolone; 8.3.1.2 Prednisolone; 8.3.2 Immunosuppressive; 8.3.2.1 Mycophenolate Mofetil (Mmf); 8.3.2.2 Ruxolitinib; 8.3.2.3 Others; 8.3.3 Calcineurin Inhibitors; 8.3.3.1 Tacrolimus (Tac); 8.3.3.2 Cyclosporin (Csa); 8.3.4 Others; 8.4 Prophylactic; 8.4.1 Cyclosporin (Csa); 8.4.2 Methotrexate (Mtx); 8.4.3 Tacrolimus (Tac); 8.4.4 Methylprednisolone; 8.4.5 Others; 8.4.5.1 Generic; 8.4.5.2 Branded; 8.4.5.2.1 Orencia; 8.4.5.2.2 Others
9 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Method Of Administration: 9.1 Overview; 9.2 Oral; 9.3 Intravenous; 9.4 Topical; 9.5 Others
10 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Treatment: 10.1 Overview; 10.2 Medication; 10.2.1 Corticosteroids; 10.2.1.1 Methylprednisolone; 10.2.1.2 Prednisolone; 10.2.2 Immunosuppressive; 10.2.2.1 Mycophenolate Mofetil (Mmf); 10.2.2.2 Methotrexate (Mtx); 10.2.2.3 Ibrutinib; 10.2.2.4 Belumosudil; 10.2.2.5 Ruxolitinib; 10.2.2.6 Antithymocyte Globulin (Atg); 10.2.2.7 Others; 10.2.3 Calcineurin Inhibitors; 10.2.3.1 Tacrolimus (Tac); 10.2.3.2 Cyclosporin (Csa); 10.2.3.3 Others; 10.2.4 Branded; 10.2.4.1 Rezurock; 10.2.4.2 Imbruvica; 10.2.4.3 Jakafi; 10.2.4.4 Orencia; 10.2.4.5 Others; 10.2.5 Generic; 10.3 Therapy
11 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Age: 11.1 Overview; 11.2 Adults; 11.3 Pediatric
12 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Gender: 12.1 Overview; 12.2 Female; 12.3 Male
13 North America Graft-versus-host-disease (Gvhd) Treatment Market, By End User: 13.1 Overview; 13.2 Hospitals; 13.2.1 Public; 13.2.2 Private; 13.3 Transplant Centers; 13.4 Institutes; 13.5 Speciality Centers
14 North America Graft-versus-host-disease (Gvhd) Treatment Market, By Distribution Channel: 14.1 Overview; 14.2 Direct Tender; 14.3 Retail Sales; 14.3.1 Hospital Pharmacy; 14.3.2 Retail Pharmacy; 14.3.3 Online Pharmacy; 14.4 Others
15 North America Graft-versus-host Disease (Gvhd) Treatment Market, By Region: 15.1 North America; 15.1.1 U.S; 15.1.2 Canada; 15.1.3 Mexico
16 North America Graft Versus Host Disease (Gvhd) Treatment Market: Company Landscape: 16.1 Company Share Analysis: North America
17 Swot Analysis
18 Company Profiles: 18.1 Bristol-myers Squibb Company; 18.1.1 Company Snapshot; 18.1.2 Revenue Analysis; 18.1.3 Company Share Analysis; 18.1.4 Product Portfolio; 18.1.5 Recent Developments; 18.2 Abbvie Inc.; 18.2.1 Company Snapshot; 18.2.2 Revenue Analysis; 18.2.3 Company Share Analysis; 18.2.4 Product Portfolio; 18.2.5 Recent Developments; 18.3 Novartis Ag; 18.3.1 Company Snapshot; 18.3.2 Revenue Analysis; 18.3.3 Company Share Analysis; 18.3.4 Product Portfolio; 18.3.5 Recent Developments; 18.4 Janssen North America Services, Llc; 18.4.1 Company Snapshot; 18.4.2 Revenue Analysis; 18.4.3 Company Share Analysis; 18.4.4 Product Portfolio; 18.4.5 Recent Developments; 18.5 Mallinckrodt; 18.5.1 Company Snapshot; 18.5.2 Revenue Analysis; 18.5.3 Company Share Analysis; 18.5.4 Product Portfolio; 18.5.5 Recent Developments; 18.6 Alkem Laboratories Ltd.; 18.6.1 Company Snapshot; 18.6.2 Revenue Analysis; 18.6.3 Product Portfolio; 18.6.4 Recent Development; 18.7 Astellas Pharma Inc.; 18.7.1 Company Snapshot; 18.7.2 Revenue Analysis; 18.7.3 Product Portfolio; 18.7.4 Recent Development; 18.8 Incyte.; 18.8.1 Company Snapshot; 18.8.2 Revenue Analysis; 18.8.3 Product Portfolio; 18.8.4 Recent Developments; 18.9 Sanofi; 18.9.1 Company Snapshot; 18.9.2 Revenue Analysis; 18.9.3 Product Portfolio; 18.9.4 Recent Developments
19 Questionnaire
20 Related Reports: Table 1 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 2 North America Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 3 North America Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 4 North America Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 5 North America Immunosuppressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 6 North America Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 7 North America Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 8 North America Acute Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 9 North America Acute Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 10 North America Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 11 North America Immunosuppressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 12 North America Calcineurin Inhibitors In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 13 North America Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 14 North America Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 15 North America Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 16 North America Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 17 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Method Of Administration, 2022-2031 (Usd Thousand); Table 18 North America Oral In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 19 North America Intravenous In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 20 North America Topical In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 21 North America Others In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 22 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Treatment, 2022-2031 (Usd Thousand); Table 23 North America Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 24 North America Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 25 North America Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 26 North America Immunosuppressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 27 North America Calcineurin Inhibitors In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 28 North America Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 29 North America Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 30 North America Therapy In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 31 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Age, 2022-2031 (Usd Thousand); Table 32 North America Adults In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 33 North America Pediatric In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 34 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Gender, 2022-2031 (Usd Thousand); Table 35 North America Female In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 36 North America Male In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 37 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By End User, 2022-2031 (Usd Thousand); Table 38 Lobal Hospitals In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 39 North America Hospitals In Graft-versus-host- Disease (Gvhd) Treatment Market, By End User, 2022-2031 (Usd Thousand); Table 40 North America Transplant Centers In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 41 North America Institutes In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 42 North America Speciality Centers In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 43 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 44 North America Direct Tender In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 45 North America Retail Sales In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 46 North America Retail Sales In Graft-versus-host- Disease (Gvhd) Treatment Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 47 North America Others In Graft-versus-host- Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 48 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Country, 2022-2031 (Usd Thousand); Table 49 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Treatment, 2022-2031 (Usd Thousand); Table 50 North America Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 51 North America Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 52 North America Immunosuppressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 53 North America Calcineurin Inhibitors In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 54 North America Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 55 North America Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 56 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 57 North America Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 58 North America Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 59 North America Immunosupressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 60 North America Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 61 North America Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 62 North America Acute Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 63 North America Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 64 North America Immunosuppressives In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 65 North America Calcineurin Inhibitors In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 66 North America Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 67 North America Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 68 North America Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 69 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Gender, 2022-2031 (Usd Thousand); Table 70 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Age, 2022-2031 (Usd Thousand); Table 71 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Method Of Administration, 2022-2031 (Usd Thousand); Table 72 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By End User, 2022-2031 (Usd Thousand); Table 73 North America Hospitals In Graft-versus-host- Disease (Gvhd) Treatment Market, By End User, 2022-2031 (Usd Thousand); Table 74 North America Graft-versus-host- Disease (Gvhd) Treatment Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 75 North America Retail Sales In Graft-versus-host- Disease (Gvhd) Treatment Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 76 U.S. Graft-versus-host- Disease (Gvhd) Treatment Market, By Treatment, 2022-2031 (Usd Thousand); Table 77 U.S. Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 78 U.S. Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 79 U.S. Immunosuppressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 80 U.S. Calcineurin Inhibitors In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 81 U.S. Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 82 U.S. Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 83 U.S. Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 84 U.S. Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 85 U.S. Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 86 U.S. Immunosuppressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 87 U.S. Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 88 U.S. Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 89 U.S. Acute Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 90 U.S. Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 91 U.S. Immunosuppressives In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 92 U.S. Calcineurin Inhibitors In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 93 U.S. Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 94 U.S. Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 95 U.S. Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 96 U.S. Graft-versus-host- Disease (Gvhd) Treatment Market, By Gender, 2022-2031 (Usd Thousand); Table 97 U.S. Graft-versus-host- Disease (Gvhd) Treatment Market, By Age, 2022-2031 (Usd Thousand); Table 98 U.S. Graft-versus-host- Disease (Gvhd) Treatment Market, By Method Of Administration, 2022-2031 (Usd Thousand); Table 99 U.S. Graft-versus-host- Disease (Gvhd) Treatment Market, By End User, 2022-2031 (Usd Thousand); Table 100 U.S. Hospitals In Graft-versus-host- Disease (Gvhd) Treatment Market, By End User, 2022-2031 (Usd Thousand); Table 101 U.S. Graft-versus-host- Disease (Gvhd) Treatment Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 102 U.S. Retail Sales In Graft-versus-host- Disease (Gvhd) Treatment Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 103 Canada Graft-versus-host- Disease (Gvhd) Treatment Market, By Treatment, 2022-2031 (Usd Thousand); Table 104 Canada Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 105 Canada Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 106 Canada Immunosuppressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 107 Canada Calcineurin Inhibitors In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 108 Canada Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 109 Canada Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 110 Canada Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 111 Canada Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 112 Canada Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 113 Canada Immunosuppressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 114 Canada Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 115 Canada Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 116 Canada Acute Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 117 Canada Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 118 Canada Immunosuppressives In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 119 Canada Calcineurin Inhibitors In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 120 Canada Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 121 Canada Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 122 Canada Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 123 Canada Graft-versus-host- Disease (Gvhd) Treatment Market, By Gender, 2022-2031 (Usd Thousand); Table 124 Canada Graft-versus-host- Disease (Gvhd) Treatment Market, By Age, 2022-2031 (Usd Thousand); Table 125 Canada Graft-versus-host- Disease (Gvhd) Treatment Market, By Method Of Administration, 2022-2031 (Usd Thousand); Table 126 Canada Graft-versus-host- Disease (Gvhd) Treatment Market, By End User, 2022-2031 (Usd Thousand); Table 127 Canada Hospitals In Graft-versus-host- Disease (Gvhd) Treatment Market, By End User, 2022-2031 (Usd Thousand); Table 128 Canada Graft-versus-host- Disease (Gvhd) Treatment Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 129 Canada Retail Sales In Graft-versus-host- Disease (Gvhd) Treatment Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 130 Mexico Graft-versus-host- Disease (Gvhd) Treatment Market, By Treatment, 2022-2031 (Usd Thousand); Table 131 Mexico Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 132 Mexico Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 133 Mexico Immunosuppressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 134 Mexico Calcineurin Inhibitors In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 135 Mexico Medication In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 136 Mexico Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 137 Mexico Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 138 Mexico Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 139 Mexico Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 140 Mexico Immunosuppressive In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 141 Mexico Chronic Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 142 Mexico Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 143 Mexico Acute Gvhd In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 144 Mexico Corticosteroids In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 145 Mexico Immunosuppressives In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 146 Mexico Calcineurin Inhibitors In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 147 Mexico Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 148 Mexico Prophylactic In Graft-versus-host- Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 149 Mexico Branded In Graft-versus-host- Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Figure 1 North America Graft-versus-host Disease (Gvhd) Treatment Market: Segmentation; Figure 2 North America Graft-versus-host Disease (Gvhd) Treatment Market: Data Triangulation; Figure 3 North America Graft-versus-host Disease (Gvhd) Treatment Market: Droc Analysis; Figure 4 North America Graft-versus-host Disease (Gvhd) Treatment Market: North America Vs Regional Market Analysis; Figure 5 North America Graft-versus-host Disease (Gvhd) Treatment Market: Company Research Analysis; Figure 6 North America Graft-versus-host Disease (Gvhd) Treatment Market: Interview Demographics; Figure 7 North America Graft-versus-host Disease (Gvhd) Treatment Market: Market Application Coverage Grid; Figure 8 North America Graft-versus-host Disease (Gvhd) Treatment Market: DBMR Market Position Grid; Figure 9 North America Graft-versus-host Disease (Gvhd) Treatment Market: Vendor Share Analysis; Figure 10 North America Graft-versus-host Disease (Gvhd) Treatment Market: Segmentation; Figure 11 The Growing Number Of Stem Cell Transplantations Is Driving The Growth Of The North America Graft-versus-host Disease (Gvhd) Treatment Market From 2024 To 2031; Figure 12 The Treatment Segment Is Expected To Account For The Largest Share Of The North America Graft-versus-host Disease (Gvhd) Treatment Market In 2024 And 2031; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Graft-versus-host Disease (Gvhd) Treatment Market; Figure 14 North America Graft-versus-host-disease (Gvhd) Treatment Market: By Type 2023; Figure 15 North America Graft-versus-host-disease (Gvhd) Treatment Market: By Type, 2024-2031 (Usd Thousand); Figure 16 North America Graft-versus-host-disease (Gvhd) Treatment Market: By Type, Cagr (2024-2031); Figure 17 North America Graft-versus-host-disease (Gvhd) Treatment Market By Type, Lifeline Curve; Figure 18 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Method Of Administration, 2023; Figure 19 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Method Of Administration, 2024-2031 (Usd Thousand); Figure 20 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Method Of Administration, Cagr (2024-2031); Figure 21 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Method Of Administration, Lifeline Curve; Figure 22 North America Graft-versus-host Disease (Gvhd) Treatment Market : By Treatment, 2023; Figure 23 North America Graft-versus-host Disease (Gvhd) Treatment Market : By Treatment, 2024-2031 (Usd Thousand); Figure 24 North America Graft-versus-host Disease (Gvhd) Treatment Market : By Treatment, Cagr (2024-2031); Figure 25 North America Graft-versus-host Disease (Gvhd) Treatment Market : By Treatment, Lifeline Curve; Figure 26 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Age, 2023; Figure 27 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Age, 2024-2031 (Usd Thousand); Figure 28 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Age, Cagr (2024-2031); Figure 29 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Age, Lifeline Curve; Figure 30 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Gender, 2023; Figure 31 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Gender, 2024-2031 (Usd Thousand); Figure 32 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Gender, Cagr (2024-2031); Figure 33 North America Graft-versus-host- Disease (Gvhd) Treatment Market : By Gender, Lifeline Curve; Figure 34 North America Graft-versus-host-disease (Gvhd) Treatment Market: By End User 2023; Figure 35 North America Graft-versus-host-disease (Gvhd) Treatment Market: By End User, 2024-2031 (Usd Thousand); Figure 36 North America Graft-versus-host-disease (Gvhd) Treatment Market: End User, Cagr (2024-2031); Figure 37 North America Graft-versus-host-disease (Gvhd) Treatment Market End User, Lifeline Curve; Figure 38 North America Graft-versus-host-disease (Gvhd) Treatment Market: By Distribution Channel 2023; Figure 39 North America Graft-versus-host-disease (Gvhd) Treatment Market: By Distribution Channel, 2024-2031 (Usd Thousand); Figure 40 North America Graft-versus-host-disease (Gvhd) Treatment Market: Distribution Channel, Cagr (2024-2031); Figure 41 North America Graft-versus-host-disease (Gvhd) Treatment Market Distribution Channel, Lifeline Curve; Figure 42 North America Graft-versus-host Disease (Gvhd) Treatment Market: Snapshot (2023); Figure 43 North America Graft Versus Host Disease (Gvhd) Treatment Market: Company Share 2023 (%)

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now